Beone Medicines Ltd. Class A · SSE:688235
Oyler John sold 283,154 Beone Medicines Ltd. Class A shares (Form 4)
Traded Jul 15 to Jul 16, 2026 · Filed Jul 17, 2026
From Jul 15 to Jul 16, 2026, Oyler John (Director, Chief Executive Officer) sold 283,154 Beone Medicines Ltd. Class A shares at an average US$315.56 for US$89.4M under a trading plan, leaving 0 shares. Filed Jul 17, 2026 (Form 4).
- Sold
- 283,154 shares
- Price
- US$315.56 average (US$310.02 to US$323.59)
- Value
- US$89.4M
- Holding after
- 0 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 15, 2026 | American Depositary Shares | Option exercise | 35,605 | US$100.04 | 35,605 | Direct |
| Jul 15, 2026 | American Depositary Shares | Option exercise | 76,677 | US$169.58 | 112,282 | Direct |
| Jul 15, 2026 | American Depositary Shares | Option exercise | 4,275 | US$160.40 | 116,557 | Direct |
| Jul 15, 2026 | American Depositary Shares | Sale | 6,067 | US$310.02 | 110,490 | Direct |
| Jul 15, 2026 | American Depositary Shares | Sale | 41,336 | US$310.92 | 69,154 | Direct |
| Jul 15, 2026 | American Depositary Shares | Sale | 12,857 | US$311.71 | 56,297 | Direct |
| Jul 15, 2026 | American Depositary Shares | Sale | 48,657 | US$312.86 | 7,640 | Direct |
| Jul 15, 2026 | American Depositary Shares | Sale | 7,640 | US$313.58 | 0 | Direct |
| Jul 16, 2026 | American Depositary Shares | Option exercise | 96,501 | US$160.40 | 96,501 | Direct |
| Jul 16, 2026 | American Depositary Shares | Option exercise | 70,096 | US$119.96 | 166,597 | Direct |
| Jul 16, 2026 | American Depositary Shares | Sale | 233 | US$311.98 | 166,364 | Direct |
| Jul 16, 2026 | American Depositary Shares | Sale | 4,881 | US$314.08 | 161,483 | Direct |
| Jul 16, 2026 | American Depositary Shares | Sale | 9,516 | US$314.73 | 151,967 | Direct |
| Jul 16, 2026 | American Depositary Shares | Sale | 19,752 | US$316.00 | 132,215 | Direct |
| Jul 16, 2026 | American Depositary Shares | Sale | 32,224 | US$316.82 | 99,991 | Direct |
| Jul 16, 2026 | American Depositary Shares | Sale | 42,798 | US$317.79 | 57,193 | Direct |
| Jul 16, 2026 | American Depositary Shares | Sale | 6,402 | US$318.55 | 50,791 | Direct |
| Jul 16, 2026 | American Depositary Shares | Sale | 15,097 | US$319.99 | 35,694 | Direct |
| Jul 16, 2026 | American Depositary Shares | Sale | 20,505 | US$321.00 | 15,189 | Direct |
| Jul 16, 2026 | American Depositary Shares | Sale | 13,109 | US$321.61 | 2,080 | Direct |
| Jul 16, 2026 | American Depositary Shares | Sale | 1,560 | US$322.71 | 520 | Direct |
| Jul 16, 2026 | American Depositary Shares | Sale | 520 | US$323.59 | 0 | Direct |
Source
Related
- Beone Medicines Ltd. Class A
- Oyler John
- Beone Medicines Ltd. Class A shareholders
- Form 4 · Oyler John · Aug 12, 2026
- Form 4 · Oyler John · Jul 22, 2026
- Form 4 · Oyler John · Jul 17, 2026
- Form 4 · Oyler John · Jul 14, 2026
- Form 4 · Oyler John · Jul 14, 2026
- Form 4 · Wang Xiaodong · Oct 15, 2026
- Form 4 · Lee Chan Henry · Oct 2, 2026
- Form 4 · Wang Xiaodong · Sep 30, 2026
- Form 4 · Baker Bros. Advisors LP · Sep 16, 2026
- Schedule 13D/A · Baker Bros. Advisors LP · Sep 16, 2026